2025年中国生物细胞资源产业链洞察报告（二）：细胞治疗CDMO

Investment Rating - The report indicates a positive investment outlook for the China cell therapy CDMO industry, highlighting its transition from technological exploration to large-scale commercialization [4]. Core Insights - The China cell therapy CDMO industry is at a critical stage of transitioning from technology exploration to large-scale commercialization, supported by favorable policies and increasing clinical pipeline activity [4]. - The industry is experiencing significant growth in demand due to the acceleration of clinical trials and product approvals, which is driving the need for CDMO services [21][26]. - The report emphasizes the importance of technological innovation and operational efficiency in enhancing the competitiveness of CDMO companies in the global market [12][29]. Summary by Sections Industry Overview - The CDMO industry is driven by high R&D costs and risks, with biotech companies emerging as key players supported by capital and policy initiatives [9]. - The industry is entering a golden development period, with a shift from scale expansion to a focus on technological depth and global expansion [10]. Demand Analysis - Global research output in cell therapy is continuously increasing, leading to higher demands for production processes and quality control [21]. - The approval of cell therapy products in China is accelerating, which enhances the demand for CDMO services to address complex production challenges [26]. Supply Analysis - CDMO companies are experiencing revenue growth with stable gross margins, indicating a strong technical drive and sustainable development capabilities [28]. - The industry is witnessing a significant differentiation, with leading companies maintaining market positions while smaller firms face structural challenges [29]. Capacity Expansion - The CDMO industry is entering a phase of large-scale capacity expansion, with multiple companies establishing new GMP production facilities to meet future commercial production demands [32][33]. Market Size Analysis - The cell therapy CDMO market is showing a clear growth trajectory, with projections indicating a significant increase in market size from 2025 to 2030 due to more pipelines entering late-stage clinical trials and commercialization [35][37].